Cyclacel Pharmaceuticals ( (CYCC) ) has released a notification of late filing.
Cyclacel Pharmaceuticals, Inc. has announced a delay in filing its Annual Report on Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The company cites the need for additional time to gather necessary information as the primary reason for the delay, which could not be avoided without unreasonable effort or expense. Cyclacel expects to file the report within fifteen calendar days following the original due date. The company does not anticipate any significant changes in its financial results compared to the previous fiscal year. Cyclacel is committed to maintaining compliance with regulatory requirements, as indicated by the signature of its CEO, Datuk Dr. Doris Wong Sing Ee, on the notification.
More about Cyclacel Pharmaceuticals
YTD Price Performance: -19.19%
Average Trading Volume: 2,380,629
Technical Sentiment Signal: Strong Buy
Current Market Cap: $61.99M
See more data about CYCC stock on TipRanks’ Stock Analysis page.